Lymphoblastic Leukemia, Acute, Childhood Completed Phase 1 Trials for Clofarabine (DB00631)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00991133A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)Treatment